Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SOPHiA GENETICS SA (SOPH : NSDQ)

• Company Description    SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. Number of Employees: 415

• Price / Volume Information    Yesterday's Closing Price: $4.88 Daily Weekly Monthly 20 Day Moving Average: 93,937 shares Shares Outstanding: 68.49 (millions) Market Capitalization: $334.21 (millions) Beta: 1.01 52 Week High: $5.70 52 Week Low: $2.59 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.21% -4.69% 12 Week 6.78% -1.28% Year To Date 4.50% -0.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL LA PIECE CH-1180 - ROLLE,V8 00000 CHE ph: 41-21-694-1060 fax: - None http://www.sophiagenetics.com

• General Corporate Information    Officers Jurgi Camblong - Chief Executive Officer Troy Cox - Chairman Ross Muken - President George Cardoza - Chief Financial Officer Tomer Berkovitz - Director Peer Information SOPHiA GENETICS SA (HLIS) SOPHiA GENETICS SA (AZTA) SOPHiA GENETICS SA (APYI) SOPHiA GENETICS SA (RNVA) SOPHiA GENETICS SA (HMSY) SOPHiA GENETICS SA (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: H82027105 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 68.49 Most Recent Split Date: (:1) Beta: 1.01 Market Capitalization: $334.21 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.32 Price/Cash Flow: - Price / Sales: 4.12 EPS Growth vs. Year Ago Period: -3.85% vs. Previous Quarter: 3.57% Sales Growth vs. Year Ago Period: 21.99% vs. Previous Quarter: -0.09% ROE 03/31/26 - -62.74 12/31/25 - -50.60 09/30/25 - -37.75 ROA 03/31/26 - -21.85 12/31/25 - -21.00 09/30/25 - -18.75 Current Ratio 03/31/26 - 2.06 12/31/25 - 1.96 09/30/25 - 2.80 Quick Ratio 03/31/26 - 1.90 12/31/25 - 1.84 09/30/25 - 2.62 Operating Margin 03/31/26 - -44.48 12/31/25 - -44.22 09/30/25 - -41.13 Net Margin 03/31/26 - -44.48 12/31/25 - -44.22 09/30/25 - -41.13 Pre-Tax Margin 03/31/26 - -98.14 12/31/25 - -100.28 09/30/25 - -98.85 Book Value 03/31/26 - 0.67 12/31/25 - 0.69 09/30/25 - 0.90 Inventory Turnover 03/31/26 - 4.03 12/31/25 - 4.15 09/30/25 - 4.00 Debt-to-Equity 03/31/26 - 1.05 12/31/25 - 1.01 09/30/25 - 0.78 Debt-to-Capital 03/31/26 - 51.15 12/31/25 - 50.31 09/30/25 - 43.95

Powered by Zacks Investment Research ©